← FDA Drug Approvals (Drugs@FDA)
CUPRIC CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EXELA PHARMA · Approved 2022-10-31
Drug application
- FDA Application #
ANDA212071- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CUPRIC CHLORIDE
- Generic name
- CUPRIC CHLORIDE
- Active ingredients
- CUPRIC CHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- EXELA PHARMA
- Manufacturer
- Exela Pharma Sciences, LLC
- First approval
- 2022-10-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown